Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines

Poster on previously shared positive results from DELIVER clinical trial in Duchenne muscular dystrophy (DMD) contextualizes observed clinical ...

Monopar Therapeutics Inc

View Monopar Therapeutics Inc MNPR stock quote prices, financial information, real-time forecasts, and company news from CNN.

What makes Simpson Manufacturing Co. (SSD) an investment bet?

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” Q4 2025 ...
Hosted on MSN

Bullish analyst opinion on Dyne (DYNE) follows rare disease drug progress in Japan

Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 13 hot stocks to buy with the highest upside potential. As of February 13, nearly 90% of analysts who cover the stock have assigned a Buy or ...

Clearbridge Small Cap Growth Strategy Added Dyne Therapeutics (DYN) in Q4

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” Q4 2025 ...

Sarepta Therapeutics shares rise on early promise for rare disease drugs

Shares of Cambridge-based Sarepta rose about 35 percent in trading Wednesday after the company presented preliminary data on ...
BioSpace

Sarepta Pushes Past Gene Therapy Debacle as RNA Therapies Show Early Promise

Biomarker data for Sarepta Therapeutics’ RNA programs, licensed from Arrowhead Pharmaceuticals, are “competitive” and “strong ...